Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002186474 | SCV002482520 | likely benign | Noonan syndrome 9 | 2021-01-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002382462 | SCV002691634 | likely benign | Cardiovascular phenotype | 2022-08-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV002186474 | SCV002763100 | likely benign | Noonan syndrome 9 | criteria provided, single submitter | clinical testing |